logo-large
  • Browse Categories

Publications by authors named "Terri Pollack"

Claim this Profile
E
Exceptional response to FOLFIRINOX in a patient with pancreatic cancer and a germline mutation.
Sofia Palacio, Terri Pollack, Rachel Silva-Smith, Daniel A Sussman, Peter J Hosein

J Gastrointest Oncol· August 2018


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant -paclitaxel and Gemcitabine in Borderline Resectable or Locally Advanced Unresectable Pancreatic Adenocarcinoma in Patients Who Are Ineligible for FOLFIRINOX.
Shawn L Peterson, Muhammad Husnain, Terri Pollack, Agustin Pimentel, Arturo Loaiza-Bonilla

Anticancer Res· July 2018


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The -paclitaxel/gemcitabine regimen for patients with refractory advanced pancreatic adenocarcinoma.
Sofia Palacio, Peter J Hosein, Isildinha Reis, Ikechukwu I Akunyili, Vinicius Ernani, Terri Pollack

J Gastrointest Oncol· February 2018


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma.
Moh'd Khushman, Naomi Dempsey, Jennifer Cudris Maldonado, Arturo Loaiza-Bonilla, Michel Velez, Terri Pollack

Pancreatology· September 2016


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: